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Abstract 
Malaria is an increasing worldwide threat, with more than three 
hundred million infections and one million deaths every year.The study was 
conducted to determine the effect of in vivo anti-plasmodial and in vitro 
antioxidant activity of ethanolic leaf extract of  Alstonia boonie  (Ewe ahun) 
and its effect on some biochemical parameters in Swiss albino mice infected 
with Plasmodium berghei NK65. Swiss albino mice were inoculated 
intraperitoneally with Plasmodium berghei NK65. The mice were grouped 
into six groups, five per group. Group I were not infected with P.berghei, 
Group II and III served both as negative and positive controls respectively, 
while Group IV, V, and VI were treated with 200, 400, and 800 mg/kg body 
weight of A. boonie leaf extract  respectively. The phytochemical 
constituents of the extract showed the presence of secondary metabolites like 
tannin, flavonoids, steroids and saponin. The extract caused 37.9%,  34.7% 
and 45.8% suppression in parasitaemia at 200, 400 and 800mg/kg body 
weight respectively while Chloroquine exerted 100% suppression at 5mg/kg 
body weight. The curative test shows that the different concentration of the 
extract exert a growth inhibition of 41.8%, 43.3% and 37.5% at 200, 400, 
800mg/kg body weight respectively while Chloroquine, cleared the parasites 
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by 93.1% at 5mg/kg body weight. The Hematological parameters showed 
that  A. boonie had a significant increase (P<0.05) in HGB, RBC and HCT 
values while their WBC count reduced significantly when compared to the 
negative control. Chloroquine and the extract significantly decreases 
(P<0.05) plasma liver marker enzymes AST, ALT, ALP and GGT in the 
treated group compared to the untreated group. The total protein values 
significantly increased (P<0.05) in the group treated with the extract and at a 
dose of 800mg/kg, the extract was nephrotoxic. In the in-vitro antioxidant 
assay, the extract significantly increase (P<0.05) the level of CAT, SOD and 
GSH in the liver homogenate induced with oxidative stress using H2O2 while 
the MDA values reduced significantly with the administration of the extract. 
 
Keywords: Alstonia boonie  (Ewe ahun) , Anti-plasmodial, Biochemical 
parameters, Plasmodium berghei NK 65 infected Swiss mice 
 
Introduction 
According to World Health Organization, malaria is an increasing 
worldwide threat, with more than three hundred million infections and one 
million deaths every year (WHO 2002). Malaria has been and is still the 
cause of major human morbidity and mortality. The classic symptoms of 
malaria are cyclical occurrence of sudden coldness followed by rigour, then 
fever and sweating lasting four to six hours, occurring every two days. 
Children with malaria frequently exhibit abnormal posturing, a sign 
indicating severe brain damage. Malaria in Nigeria is holoendemic i.e. there 
is an intense all-year round transmission with greater intensity in the wet 
season than dry season.The most important problems associated with malaria 
is that Plasmodial parasites are resistant to most widely available and 
affordable drugs like Fansidar and Chloroquine (Kisame, 2005). Secondly, 
the control of mosquitoes which transmits malaria is made difficult by their 
resistance to a wide range of insecticides. Thirdly, is the production of fake 
antimalarial drugs.  Lastly, most countries in Africa lack the necessary 
infrastructure and resources to manage and control malaria (WHO, 1994). 
Plasmodium berghei has been used in studying the activity of potential 
antimalarials in mice (Pedronic,et al.2006 ) and in rats (English, et al 1996 ). 
It produces diseases similar to those of human plasmodium infection (Kumar 
at al,2006 and Peter,1998 ). 
Medicinal plants are known to contain a variety of substances and are 
used in the treatment of many kinds of ailments in traditional medicine. 
Medicinal plants have the basis of health care throughout the world and 
remain relevant both in the developing and developed nations of the world 
for various chemotherapeutic purposes. A number of traditional herbs have 
been tested and used in the prevention and also treatment of malaria. 
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Alstonia boonei   De Wild is large deciduous evergreen tree, usually up to 
45m tall and 1.2m in diameter. It belong to the family Apocynaceae which 
consist of more than 40 species widely distributed in the continents of 
Africa, Asia and America (Iwu, 1993 and Ojewole,1984). Alstonia boonei is 
known as Ahun in Yoruba, Egbu-ora in Igbo, Ukhu in Edo and Ukpukunu in 
Urhobo. Different parts of the plant are employed for the treatment of a 
variety of ailments in traditional medicine, to treat malaria, fever, rhematic 
pains, chronic diarrhea, insomnia, as anti-venom for snake bites and in the 
treatment of arrow poisoning (Koumaglo et al,1992, Asuzu, 1991 and Obih, 
1985). 
 
Materials and methods 
Collection and Preparation of Plant extract 
The leaves of   Alstonia boonei  were obtained from Abeokuta in 
Ogun State, Nigeria with the help of  a traditional herbalist. The plant was 
authenticated by Miss Shokefun a botanist from SLT Department, 
Environmental biology Unit, Lagos State Polytechnic, Ikorodu. The leaves 
were washed, air dried under shade in the Biochemistry Laboratory, 
pulverised to coarse power using blender. Extraction was carried out by 
dispersing 200g of the grounded Alstonia boonei  plant material in 1L of 
70% ethanol and shaking was done with GFL shaker for 72 hours. This was 
followed by vacuum filtration and concentrated by rotary evaporator at a 
temperature not exceeding 40oC. The concentrated extract was dried to 
complete dryness in an aerated oven at 40oC for 48 hours. The Alstonia 
boonei  ethanolic extract was latter stored in a refrigerator at 4oC. 
 
Phytochemical analysis 
Phytochemical analysis for bioactive constituents were carried out on 
the ethanolic extract of  Alstonia boonei  using standard phytochemical 
procedures (Sofowora (1993), Harborne (1973), Trease and Evans (1993)).  
 
Experimental Swiss albino mice 
Seven (7) weeks old Swiss albino mice weighing 22- 32g were 
obtained from Nigeria Institute of Medical Research (NIMR), Lagos, 
Nigeria. They were acclimatized for seven days, housed in plastic 
cages with saw dust as beddings; food and water were given ad 
libitum. The mice were used in accordance with NIH Guide for the 
care and use of laboratory animals; NIH Publication revised (1985) 
NIPRD Standard Operation Procedures (SOPs). 
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Acute toxicity test 
The acute toxicity test of ethanolic leaf extract of Alstonia 
boonei  was carried out using modified Lorkes method (1993). 
Eighteen Swiss albino mice weighing 22 to 32 grams were randomized 
into three groups of six mice each and were given 1600, 2900 and 
5000mg/Kg body weight of the extract orally. They were observed for 
signs of toxicity and mortality for the first critical four hours and 
thereafter daily for 7 days. The oral median dose LD50 was calculated 
 
Animal grouping for infection and treatment 
The parasite Plasmodium berghei NK 65 was obtained from 
Nigeria Institute of Medical Research (NIMR), Lagos, Nigeria from 
Dr Aina, O.O. The parasites were kept alive by continuous 
intraperitoneal inoculation of known amount of the parasite into Swiss 
mice. Iml of blood was taken from donor mice and diluted with 5ml 
phosphate buffer; such that 0.1ml contained standard inoculum of 1 × 10 7 infected red blood cells (Maegraith et al, 1952). Thirty 
acclimatized Swiss albino mice were randomly selected and twenty 
five Swiss mice were inoculated intraperitoneally from the same 
source to avoid variability in parasitemia. The mice were randomly 
distributed into six groups of five per group as shown below: 
 GROUP I (Normal control ) Healthy Swiss mice 
 GROUP II (Negative control) mice infected with P.berghei 
NK65 received no treatment 
 GROUP III. (Positive control) = P.berghei +5mg/kg b,wt of 
chloroquine (Standard drug) 
 GROUP IV = P. berghei +  200mg/kg b.wt of A. boonei  
extract. 
 GROUP V =  P. berghei + 400mg/kg b.wt of A. boonei  
extract. 
 GROUP VI=P. berghei  + 800mg/kg b.wt  of A. boonei  
extract. 
 
Anti-plasmodium studies 
Suppressive test 
The Peter’s 4-day suppressive test against P. berghei NK65 infection 
in Swiss mice was used (Peters, 1965). Adult Swiss mice weighing between 
22 to 32g were inoculated by intraperitonial injection with standard 
inoculum of Plasmodium berghei NK65 with 1 × 107  infected red blood 
cells. The mice were divided into six groups as shown above and treated for 
4 consecutive days with 5mg/kg.b.wt of Chloroquine, 200, 400, and 
800mg/kg body weight of  Alstonia boonei  extract orally daily. On day 5 of 
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the experiment, blood was collected from the tail of each mouse and 
smeared onto microscope slide to make a film.  The blood films were fixed 
with methanol, stained with Geimsa at pH 7.2 for 10 minutes and examined 
under the microscope for the presence of parasites. The parasite density was 
calculated for each group by comparing the parasitaemia in infected group 
(Group II) with those of control and those of treated mice.  
 
Curative test 
The Curative test of ethanolic leaf extract of  Alstonia boonei  on 
another fresh infected Swiss albino mice were carried out according to the 
method described by Ryley and Peters, 1970.  The mice were injected 
intraperitoneally with standard inoculums of 1×107 Plasmodium berghei NK 
65 infected erythrocytes on the first day (day 0). Seventy two hours later, 
thirty mice were divided into six groups of five mice per group as shown 
above. The groups were orally treated with 5mg/kg b.wt of chloroquine and 
Alstonia boonei  leaf extract (200,400 and 800mg/kg b.wt respectively). The 
treatment was carried out once daily for 5 days, on each day of the 
treatment, blood was collected from the mice tail and smeared onto 
microscope slide to make thin and thick films. The blood films were fixed 
with methanol, stained with 10% Giemsa at pH 7.2 for 10 minutes and 
examined microscopically to monitor the parasitaemia level. The parasite 
density was calculated for each group over a period of six days. 
 
Hematological analysis 
The Swiss albino mice in the suppressive assay groups were 
sacrificed and their bloods were collected in EDTA bottles by ocular 
puncturing. The bloods in the EDTA bottles were assayed using BC -3200 
Auto Hematology Analyzer in Lagos University Teaching Hospital in 
Lagos- Nigeria. 
 
Determination of liver and kidney function test 
Plasma enzymes like aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), alkaline phosphatase (ALP) and gamma glutamyl 
transferase (GGT) were determined by Randox diagnostic kits. The total 
protein, urea and creatinine were also determined using Randox diagnostic 
kits. 
 
In-vitro antioxidant assay 
Three new healthy albino rats were scarified and their liver were 
removed and used for the assay. One gram of albino rat liver slice was taken 
in 4ml sterile PBS in flat bottom flask. H2O2 at 0.5M concentration was used 
as an oxidant for the induction of oxidative stress in the liver slices.  100µl of 
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ethanolic leaf extract of  A. boonei  were added and later incubated for 1 hour 
at 37oc. 
Group A: 1g of untreated liver slice (negative control) 
 B: 1g of liver slice + H2O2 (positive control) 
 C: 1g liver slice +  200mg of  A. boonei  extract 
 D: 1g liver slice + H2O2  + 200mg of  A. boonei  extract 
 E: 1g liver slice +  H2O2 + 400mg of A. boonei extract 
   F: 1g liver slice + H2O2 + 800mg of A. boonei extract 
After incubation for 1 hour, an homogenate was prepared from the 
slices using 10% (W/V) PBS buffer. The homogenate was centrifuged at 
1500rpm for 10 minutes to clarify the debris and the supernatant was used 
for the antioxidant assay. 
 
Estimation of Lipid peroxidative (LPO) indices 
Lipid peroxidation as evidenced by the formation of thiobarbituric 
acid (TBARS), malondialdehyde (MDA) and hydroperoxide (HP). These 
parameters were measured in the liver homogenate by the method of 
Niechaus and Sameulsson and Jiang et al, 1992. 
 
Estimation of superoxide dismutase (SOD) 
The homogenate was assayed for the presence of SOD by utilizing 
the technique of magwere et al 1997 with slight modification. 
 
Estimation of catalase (CAT) 
The liver homogenate was assayed for catalase colorimetrically at 
620mm and expressed as µmoles of H2O2 consumed/min/mg protein as 
described by sinha. 
 
Estimation of Reduced glutathione (GSH) 
Reduced glutathione (GSH) was determined in the liver homogenate 
using the method of Ellman. 
 
Data analysis 
Data analysis was done using the Graph Pad prism computer 
software. Student’s’-test and one-way analysis of variance (ANOVA) were 
used for comparison. A P-value < 0.05 was 
considered significant. 
 
Results 
The results obtained from the phytochemicals analysis of  Alstonia 
boonei  extract showed the presence of some secondary metabolite like 
tannins, saponins, steroids, flavonoids, protein, reducing sugar and fats 
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and oil. (Table I). The presence of these secondary metabolites in this 
extract may be responsible for the anti-plasmodial activity of Alstonia 
boonei .  
Table I.  The phytochemical screening of Alstonia boonei. leaf extract. 
Phytochemical analysis test Qualitative abundance 
Alkaloids + 
Tannins (Ferric chloride test) ++ 
Saponins (Emulsion test) + + 
Steroids (Salkowski test) ++ 
Flavonoids ( Ammonium test) ++ 
Protein (Million test) + 
Reducing Sugar (Fehling solution) ++ 
Fat and Oil (Stain test) + 
(+) present at low levels and (++) present at moderate levels. 
 
Table 2: Suppressive and curative test showing the effect of chloroquine and  
Alstonia boonei ethanolic leaf extract against Plasmodium berghei NK65 infected 
Swiss mice. 
Treatment Dose (mg/kg) 
Parasite Density for 
suppressive 
(%) growth 
Inhibition for 
suppressive test 
Parasite 
Density for 
curative test 
(%) growth 
Inhibition 
for curative 
Test 
Group I NHC NIL NIL NIL NIL 
Group II NC 169982.52 00.00 1701652.21 00.00 
Group III 5mg/kg (PC) NIL from 3rd day** 
 
100** 
NIL from 3rd 
day** 
 
93.1** 
Group IV 200mg/kg 105519.73* 37.9 989618.80* 41.8 
Group V 400mg/kg 110947.14* 34.7 964840.43* 43.3 
Group VI 800mg/kg 92181.30* 45.8 1062974.5* 37.5 
NHC=Normal healthy control group, NC=Negative control, PC=Positive control. 
*Significantly different from the NC at P<0.05, ** highly significant difference from the NC 
at P<0.05. 
 
The ethanolic leaf extract of  A. boonei caused 37.9%,  34.7% and 
45.8% suppression in parasitaemia of P.berghei NK65 infected mice at 200, 
400 and 800mg/kg body weight respectively (Table 2), while Chloroquine, a 
standard anti-malarial drug used exerted 100% suppression at 5mg/kg body 
weight. The curative test shows that the different concentration of the 
extract of A. boonei exert a growth inhibition of  41.8%, 43.3% and  37.5% 
at 200, 400, 800mg/kg body weight of the extract respectively while 
Chloroquine, the standard drug, cleared the parasites by 93.1% at 5mg/kg 
body weight. 
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Table 3: Suppressive effect of ethanolic leaf extract of  Alstonia boonie  and chloroquine on 
hematological parameters of Swiss albino mice infected with P. berghei NK65. 
Hematological 
Parameters 
Group 
I 
Group 
II 
Group 
III 
Group 
IV 
Group 
V 
Group 
VI 
WBC (X 109/L) *7.6 ±1.1* 14.10 ±2.10 9.10 ±0.6* 10.5 ±1.03* 11.4 ±0.20* 10.4 ±0.23* 
PCT 
(%) 
0.458 
± 0.059 
0.322 
± 0.071 
0.391 
± 0.068 
0.371 
± 0.035 
0.501 
± 0.133 
0.317 
± 0.051 
MPV (fL) 6.6 ± 0.2 6.9 ± 0.2 6.7 ± 0.10 7.0 ± 0.10 6.9 ± 0.2 7.0 ± 0.2 
PDW 14.20±0.10 14.50±0.20 14.1±0 .2 14.3±0.20 14.90±0.30 14.60±0.20 
HGB   (g/dl) 14.3±1.60* 8.7±1.2 10.6±1.20* 12.10±0.20* 11.60±0.3* 13.4±0.4* 
RBC (X 1012/L) 9.10±0.5* 6.80 ± 0.4 8.20±0.43* 8.30±0.23* 8.68±0.22* 8.7±0.40* 
HCT (%) 48.3±0.8* 32.2±6.5 44.1±0.4* 41.2±0.9* 40.11±2.1* 42.7±5.4* 
MCV (fL) 54.22±3.4 53.30±3.2 54.10±2.4 52.11±0.50 52.00±0.30 52.20±0.70 
MCH (Pg) 15.7±0.7 14.8±0.4 15.0±0.4 14.70±0.60 13.90±0.90 14.90±0.50 
MCHC (g/dL) 31.10±0.20 29.10±1.20 31.40±0.30 29.00±0.20 27.23±0.37 28.80±0.23 
RDW-CV (%) 17.70±0.50 18.10±0.10 17.90±0.20 17.70±0.41 17.60±0.40 17.20±0.22 
RDW-SD (fL) 30.40±0.20 31.40±0.50 31.10±0.30 32.20±0.40 30.80±0.30 30.60±1.10 
 
Values are expressed in mean ± SD of five mice in each group. * 
indicate Significant difference when compared to negative control (P <0.05). 
WBC: White blood cell; PCT: Plateletcrit ; MPV: Mean platelet volume; 
PDW: Platelet Distribution Width; HGB: Hemoglobin Concentration; RBC: 
Red Blood Cell; HCT: Hematocrit ; MCV: Mean corpuscular volume; MCH: 
Mean Cell hemoglobin; MCHC: Mean Cell hemoglobin concentration; 
RDW–CV: RBC distribution width–coefficient of variation; RDW–SD: RBC 
distribution width–standard deviation. 
The total WBC counts of the treated mice were significantly lowered 
following the administration of chloroquine and the extract of Alstonia 
boonie.  The mean HGB, RBC and HCT values of the infected untreated 
mice (group II) were significantly ( P<0.05) lowered when compared to 
group I and all other groups ( Table 3). The other Hematological parameters 
show no significant differences between the untreated group and other 
groups. 
Table 4: Determination of Plasma Total protein, Liver and Kidney function test 
of uninfected group and infected groups treated with chloroquine and the extract. 
Hematological 
Parameters 
Group 
I 
Group 
II 
Group 
III 
Group 
IV 
Group 
V 
Group 
VI 
AST (U/L) 5.20 ±1.50* 11.10 ±4.0 6.20 ± 2.10* 8.10 ±1.20* 8.00 ±1.0* 9.60 ±1.4* 
ALT (U/L) 4.50±1.00* 17.10±5.10 6.80±1.10* 6.00±2.00* 8.80±1.20* 9.00±1.20* 
ALP (U/L) 66.30±2.10* 109 ±4.30 68.40±1.40* 70.10±5.40* 68.20±4.2* 73.80±5.40* 
GGT (U/L) 14.40 ± 3.2* 45.4 ±3.2 18.20±5.30* 32.0±2.30* 24.20±2.0* 28.10±2.1* 
Creatinine (mg/dl) 0.81 ± 0.020* 1.71 ± 0.15 1.25 ± 0.20* 1.81 ± 0.240 1.90 ± 0.30 2.20 ± 0.21 
Urea (mg/dl) 20.10±4.20* 29.50±1.50 24.5±2 .30* 30.20±1.80 29.40±2.20 31.10±3.10 
Total protein (g/l) 76.80±4.00* 58.50±5.60 67.10±3.20* 65.20±2.20* 64.20±3.4* 68.40±2.10* 
* indicate Significant difference (P <0.05) when compared to negative control animals. 
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Figure 1: The effect of A. boonei on the activities  of CAT in liver homogenate induced with
oxidative stress using H2O2.
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Figure 2: The effect of A. boonei on the activities  of SOD in liver homogenate induced with
oxidative stress using H2O2.
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Figure 3: The effect of A. boonei on the level  of GSH in liver homogenate induced with
oxidative stress using H2O2.
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Figure 4: The effect of A. boonei on the levels of lipid peroxidation indices in liver
homogenate induced with oxidative stress using H2O2.
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Discussion 
The presence of pharmacologically active phytochemicals like 
steroids, reducing sugar, saponins, tannins, protein, flavonoids , fats and oil 
have been shown to be present in the extract ( Table I). ). The presence of 
these secondary metabolites in A. boonei, may be responsible for their anti-
plasmodium activity. Anti-plasmodial screening of plant substances have 
been shown to be caused by alkaloids, terpenes and flavonoids (Philipson, 
1990, Milliken, 1997 and Christensen, 2001 ) . These compounds could be 
acting singly or in synergy with one another to exert the anti-plasmodial 
activity observed in this study. It is evident by these findings that A. boonei 
possessed anti-plasmodium activity justifying its usage in the management of 
malaria in Nigeria. David, 2004 and Okokon, et al.2008 showed clearly that 
Saponin, flavonoids and tannins have been suggested to act as primary 
antioxidant or free radicals scavengers that can counteract the oxidative 
damage induced by malaria parasite. 
Toxicity test shows that no death occurred at all the dose level used 
which shows that the extract does not have any toxic effect that can lead to 
the death of the mice. The median lethal dose LD50 was estimated to be ≥ 
5000mg/Kg body weight. Behavioural signs of toxicity like stretching, 
salivation, paw licking, severe reduced activities and respiratory distress 
were observed. 
Plasmodium berghei parasite is used in predicting treatment 
outcomes of any suspected antimalaria agent due to its high sensitivity to 
chloroquine making it the appropriate parasite for this study (peter, 1998 and 
David, 2004). Plasmodium berghei has been used in studying the activity of 
potential antimalarials in mice (Pedronic,et al.2006 ) and in rats (English, et 
al 1996 ). It produces diseases similar to those of human plasmodium 
infection (Kumar at al,2006 and Peter,1998 ). 
Suppressive test is a standard test commonly used for anti-malarial 
screening and the determination of percent inhibition of parasitaemia is the 
most reliable parameter. There were significant decrease (P<0.05) in parasite 
density in the treated group (group III to VI) compared to the untreated 
group (group II). Chloroquine drug used in this study exerted 100% 
suppression at 5mg/kg body weight (Table 2). Kiseko et al, 2000 showed 
that when a standard anti-malarial drug is used in mice infected with 
P.berghei, it suppresses the parasiteamia to a non-detectable level which is in 
line with our study. A.boonie ethanolic extract caused 37.9%, 34.7% and 
45.8% suppression in parasitaemia of P.berghei infected mice at 200, 400 
and 800mg/kg body weight respectively. The significant decrease in 
parasitaemia observed in this study was dose dependent.  
Ethanolic leaf extract of  Alstonia boonie showed marked anti-
malarial effect in dose seeming fashion from the percentage parasitaemia 
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computed after carrying out curative test. The curative test showed that only 
Chloroquine (standard drug) cleared the parasites by 93.1% while the 
different concentration of the extracts exert a growth inhibition of  41.8%, 
43.3% and  37.5% at 200, 400, 800mg/kg body weight of the extract 
respectively (Table 2). 
Studies have showed that hematological and biochemical indices 
have been reported to be a reliable parameter for assessment of the health 
status of animals (Sexena ,et al 2011 and Ohaeri, 2011). WBC functions in 
the body defense against foreign bodies and this is often achieved through 
leucocytosis and antibody production (Marieb, 1995). There were significant 
increases  
(P < 0.05) in the WBC count in group II compared to group III and 
all the groups treated with A.boonie  extract (Table 3). Leukocytosis 
observed in group II may be due to bone marrow tumor, luekemia, tissue 
damage, and inflammatory disease of the mice infected with P.berghei 
NK65. The values of parasitaemia were significantly high (P<0.05) in the 
treated group (group III to VI) compared to the healthy group because some 
of the parasites were still present in the mice.  There were significant 
increase (P<0.05) in HGB, RBC and HCT of the group treated with 
Chloroquine  and A.boonie extract compared to the untreated infected mice. 
The extracts prevented a drastic reduction in HGB, RBC and HCT values, 
features signifying severe anemic conditions. The hemolysis of blood may be 
due to non-immune destruction of parasitized red cells in case of high 
parasitemia or immune mediated destruction of parasitized cell as well as 
non-parasitized red cells because the changes in the red cell antigen structure 
brought about by the parasitic invasion stimulate the production of antibodies 
against the red cell. This triggers immune immediate red cell lysis. This 
study is in accordance with the report of Aleksandro, et al 2009. They 
observed that anemia is characterized by decreased values of HGB, RBC and 
HCT Gavigan et al., 2001 observed that the growing parasite consumes and 
degrades the intracellular proteins which are mainly hemoglobin, this may 
account for the decreased in Hemoglobin.  
There were also significant increase (P<0.05) in HGB, RBC and 
HCT of the healthy mice (group I) compared to the group treated with 
chloroquine  and A.boonie extract (group III-VI ) respectively. This may be 
due to the destruction of RBC and HGB by the P. berghei during treatment. 
There were no significant change (P<0.05) in the MPV, PCT, MCV, MCH, 
MCHC, PDW, RDW-CV.and RDW-SD values in the entire experimental 
groups 
Table 4 shows that there is a significant increase (P>0.05) in plasma 
AST, ALT, ALP and GGT in the untreated mice compared to other treated 
mice. This shows that the mice in group I have liver impairment or 
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hepatocellular damage compared to other mice in other groups. Increase in 
the serum levels of AST and ALT (especially ALT) are reported to be 
associated with liver damage (Mukherjee, 2003). Halim, et al, 1997, Momoh 
et al, 2014, Momoh and Manuwa, 2014 showed clearly that increase in 
plasma ALP and GGT levels is associated with liver damage. There were 
significant increase (P>0.05) in the plasma creatinine and Urea values 
obtained in the infected untreated group compared to group I, III, IV and V. 
Mice treated with 800mg/kg body weight of the extract causes significant 
increase in creatinine and urea values compared to the untreated infected 
mice. This is an indication that Alstonia boonei leaf extract may be 
nephrotoxic at high dose and could cause kidney damage. There were 
significant decrease (P<0.05) in the plasma total protein in group II 
compared to other groups. This may be due to the reduction in protein 
synthesis. Since malaria parasite causes the destruction of cells that are 
responsible for protein synthesis. This finding agrees with an earlier report 
that showed that chronic infections and autoimmune diseases may lead to 
reduced protein synthesis. 
Liver is the major organ used for removing xenobiotic substances 
from the body and as such is subjected to many substances causing oxidative 
stress. In the in-vitro antioxidant assay, there were a significant reduction 
(P<0.05) in activities of CAT and SOD in liver homogenate in group B 
compared to group A, C, D, E, F (Figure I and 2). The reduced levels of 
antioxidant enzymes (SOD and CAT) in group B liver homogenate clearly 
indicate hepatocytes necrosis due to production of reactive oxygen species. 
Group A, C, D, E and F have higher GSH values (P<0.05) compared to 
group B (Figure 3). Low GSH value has been implicated with oxidative 
stress. MDA values significantly increase (P<0.05) in the liver homogenate 
of group B compared to group A, C, D, E and F (Figure 4).  This indicates 
hepatic injury as a result of oxidative stress caused by H2O2 . Increase in 
MDA value indicates increased in lipid peroxidation which could have 
resulted from the depletion of GSH concentration. 
 
Conclusion 
The result obtained from this study reveals that 200, 400 and 
800mg/kg body weight of Alstonia boonie ethanolic leaf extract suppresses 
Plasmodium berghei NK 65 and could be used in the management of 
malaria. The extract has positive effect on some biochemical parameters and 
may cause kidney damage at high dose. 
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